SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹90 Cr | ₹65 Cr | ₹58 Cr | ₹54 Cr | ₹31 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹65 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹54 Cr |
| Mar2021 | ₹31 Cr |
How is Deferred Tax Assets / Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹90 Cr | 39.57 | |
| Mar2024 | ₹65 Cr | 11.26 | |
| Mar2023 | ₹58 Cr | 7.22 | |
| Mar2022 | ₹54 Cr | 75.59 | |
| Mar2021 | ₹31 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹18,841.1 Cr | -4.8% | -8% | -53.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,631.0 Cr | 1.9% | -0.8% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,111.0 Cr | 3.2% | 4.8% | 12.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,228.0 Cr | 6.3% | 8.9% | 15.8% | Stock Analytics | |
| CIPLA | ₹117,983.0 Cr | -3.3% | -2% | -1.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,782.0 Cr | -3.8% | -3.1% | -8% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -4.8% |
-8% |
-53.9% |
| SENSEX | -1.2% |
-1.1% |
6.3% |
You may also like the below Video Courses